Depressive Symptoms Clusters and Insulin Resistance: Race/Ethnicity as a Moderator in 2005–2010 NHANES Data

Annals of Behavioral Medicine

Volumn 50, Issue 1, 2016, Pages 1-11

  Vrany, Elizabeth A ^a   Berntson, Jessica M ^a   Khambaty, Tasneem ^a   Stewart, Jesse C ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Depression; Depressive symptom clusters; Diabetes; Insulin resistance; NHANES; Race ethnicity

Indexed keywords

ADULT; BIOLOGICAL MODEL; CAUCASIAN; DEPRESSION; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; DEPRESSION; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 84957436710     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-015-9725-0     Document Type: Article

References (69)

1. Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev. 2011; 31: 1239-1246.
2. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012; 142: S8-S21.
3. Rustad JK, Musselman DL, Nemeroff CB. The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology. 2011; 36: 1276-1286.
4. Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006; 49: 837-845.
5. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008; 31: 2383-2390.
6. Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010; 53: 2480-2486.
7. Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008; 299: 2751-2759.
8. Ismail K. Unraveling the pathogenesis of the depression-diabetes link. In: Katon W, Maj M, Norman S, eds. Depression and diabetes. Chichester, UK: Wiley & Sons; 2010.
9. Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev. 2007; 3: 252-259.
10. Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res. 2002; 53: 873-876.
11. Silva N, Atlantis E, Ismail K. A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes? Curr Psychiatry Rep. 2012; 14: 8-14.
12. Shepherd PR, Kahn BB. Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999; 341: 248-257.
13. Ryan JP, Sheu LK, Critchley HD, Gianaros PJ. A neural circuitry linking insulin resistance to depressed mood. Psychosom Med. 2012; 74: 476-482.
14. Kan C, Silva N, Golden SH, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013; 36: 480-489.
15. Stewart JC, Zielke DJ, Hawkins MA, et al. Depressive symptom clusters and 5-year incidence of coronary artery calcification: the coronary artery risk development in young adults study. Circulation. 2012; 126: 410-417.
16. Carney RM, Freedland KE. Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease? Psychosom Med. 2012; 74: 33-38.
17. Davidson KW, Rieckmann N, Rapp MA. Definitions and distinctions among depressive syndromes and symptoms: implications for a better understanding of the depression–cardiovascular disease association. Psychosom Med. 2005; 67(Suppl 1): S6-9.
18. Khambaty T, Stewart JC, Muldoon MF, Kamarck TW. Depressive symptom clusters as predictors of 6-year increases in insulin resistance: data from the Pittsburgh Healthy Heart Project. Psychosom Med. 2014; 76: 363-369.
19. Austin AW, Gordon JL, Lavoie KL, et al. Differential association of insulin resistance with cognitive and somatic symptoms of depression. Diabet Med. 2014; 31: 994-1000.
20. Case SM, Stewart JC. Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005–2010 NHANES data. Brain Behav Immun. 2014; 2014(41): 101-108.
21. Fisher L, Skaff MM, Mullan JT, et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008; 25: 1096-1101.
22. Katon W, Fan MY, Unutzer J, et al. Depression and diabetes: a potentially lethal combination. J Gen Intern Med. 2008; 23: 1571-1575.
23. Bunt JC, Krakoff J, Ortega E, Knowler WC, Bogardus C. Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations. Diabetes Metab Res Rev. 2007; 23: 304-310.
24. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000; 106: 453-458.
25. Van der Kooy K, van Hout H, Marwijk H, et al. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry. 2007; 22: 613-626.
26. Utzschneider KM, Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006; 91: 4753-4761.
27. Liao MT, Sung CC, Hung KC, et al. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol. 2012; 2012: 691369.
28. Barbour LA, McCurdy CE, Hernandez TL, et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007; 30(Suppl 2): S112-119.
29. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33(Suppl 1): S62-69.
30. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
31. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002; 32: 509-515.
32. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry. 2007; 29: 388-395.
33. Patten SB, Schopflocher D. Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9). Compr Psychiatry. 2009; 50: 26-33.
34. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012; 184: E191-196.
35. Cameron IM, Cardy A, Crawford JR, et al. Measuring depression severity in general practice: discriminatory performance of the PHQ-9, HADS-D, and BDI-II. Br J Gen Pract. 2011; 61: e419-426.
36. Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006; 21: 547-552.
37. Chilcot J, Rayner L, Lee W, et al. The factor structure of the PHQ-9 in palliative care. J Psychosom Res. 2013; 75: 60-64.
38. Krause JS, Bombardier C, Carter RE. Assessment of depressive symptoms during inpatient rehabilitation for spinal cord injury: is there an underlying somatic factor when using the PHQ? Rehabil Psychol. 2008; 53: 513-520.
39. de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med. 2007; 69: 735-739.
40. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.
41. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27: 1487-1495.
42. Everson-Rose SA, Meyer PM, Powell LH, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care. 2004; 27: 2856-2862.
43. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23: 57-63.
44. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002; 19: 527-534.
45. Baliunas DO, Taylor BJ, Irving H, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009; 32: 2123-2132.
46. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003; 45: 405-413.
47. Freedland KE, Carney RM, Skala JA. Depression and smoking in coronary heart disease. Psychosom Med. 2005; 67(Suppl 1): S42-46.
48. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71: 171-186.
49. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444: 840-846.
50. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010; 67: 220-229.
51. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-1801.
52. Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med. 2005; 118: 330-341.
53. Yin J, Li M, Xu L, et al. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013; 5: 71.
54. Reinehr T, Andler W. Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res. 2004; 62: 107-112.
55. Esteghamati A, Ashraf H, Khalilzadeh O, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010; 7: 26.
56. Blaine B. Does depression cause obesity? A meta-analysis of longitudinal studies of depression and weight control. J Health Psychol. 2008; 13: 1190-1197.
57. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27: 24-31.
58. Wiltink J, Michal M, Wild PS, et al. Associations between depression and different measures of obesity (BMI, WC, WHtR, WHR). BMC Psychiatry. 2013; 13: 223.
59. Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BW. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology. 2013; 38: 1573-1585.
60. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun. 2009; 23: 936-944.
61. Michal M, Wiltink J, Kirschner Y, et al. Differential associations of depressive symptom dimensions with cardio-vascular disease in the community: results from the Gutenberg health study. PLoS One. 2013; 8, e72014.
62. Deverts DJ, Cohen S, DiLillo VG, et al. Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom Med. 2010; 72: 734-741.
63. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome—from insulin resistance to obesity and diabetes. Endocrinol Metab Clin North Am. 2008; 37: 559-579. vii.
64. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J. 2005; 149: 33-45.
65. Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci. 2006; 1083: 329-344.
66. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014; 31: 764-772.
67. Twist K, Stahl D, Amiel SA, et al. Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med. 2013; 75: 791-797.
68. Hybels CF, Steffens DC, McQuoid DR, Rama Krishnan KR. Residual symptoms in older patients treated for major depression. Int J Geriatr Psychiatry. 2005; 20: 1196-1202.
69. Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011; 41: 1165-1174.